Virpax Pharmaceuticals stock is up on Monday as VRPX investors react to new funding and changes to the company's board of directors. More
Articles
3 Dividend Aristocrats to Buy for Retirement: July Edition
Investors looking for high yields and respectable returns may want to monitor these dividend aristocrats to buy. More
LEDS Stock Earnings: SemiLEDs Reported Results for Q3 2024
SemiLEDs just reported results for the third quarter of 2024. More
RIVN Stock Alert: Rivian Chief Accounting Officer Jeffrey Baker Resigns
Rivian CAO Jeff Baker will resign, effective as of July 27. CFO Claire McDonough will step in as interim CAO during the replacement process. More
3 Undervalued Stocks on Track to Double (or More) by 2028
The stock market is on the brink of a multi-year bull market. Consider these undervalued growth stocks to buy that can double or more by 2028. More
Microsoft Layoffs 2024: What to Know as MSFT Enacts More Job Cuts
Microsoft layoffs hit the tech giant's employees last week as it reduced an unknown number of roles in two of its divisions. More
3 Underappreciated Dividend Gems Primed for a Breakout
These are some of the top dividend stocks to buy that can generate long-term returns for patient investors. More
